sumatriptan has been researched along with Hypesthesia in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Hypesthesia: Absent or reduced sensitivity to cutaneous stimulation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "More sumatriptan-treated patients were completely pain free compared with placebo-treated patients at both 2 h (24% versus 12%) and 4 h (48% versus 18)." | 2.67 | Oral sumatriptan compared with placebo in the acute treatment of migraine. ( Byrne, M; Nappi, G; Roncolato, M; Sicuteri, F; Zerbini, O, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nappi, G | 1 |
| Sicuteri, F | 1 |
| Byrne, M | 1 |
| Roncolato, M | 1 |
| Zerbini, O | 1 |
1 trial available for sumatriptan and Hypesthesia
| Article | Year |
|---|---|
Oral sumatriptan compared with placebo in the acute treatment of migraine.
Topics: Acute Disease; Administration, Oral; Adult; Double-Blind Method; Female; Fever; Humans; Hypesthesia; | 1994 |